Emmanuel Drouet
Inventor
Stats
- 2 US patents issued
- 8 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 2 US Patents Issued
- 8 US Applications Filed
- 6 Total Citation Count
- May 8, 2015 Most Recent Filing
- Aug 15, 1997 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| INSTITUT PASTEUR | 1
1 | 2007
2009 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) | 1
1 | 2012
2015 |
| UNIVERSITE JOSEPH FOURIER | 1
1 2 3 1 | 1997
2007 2009 2012 2015 |
| PARTEUROP DEVELOPPEMENT | 1
| 1997
|
| BIOMERIEUX | 1
1 | 2012
2015 |
| UNIVERSITE GRENOBLE ALPES | 1
| 2015
|
Inventor Addresses
| Address | Duration |
|---|---|
| Corenc, FR | Jan 08, 02 - Jul 04, 17 |
| Grenoble cedex 9, FR | Dec 22, 11 - Aug 27, 15 |
| Grenoble cedex, FR | Feb 28, 13 - Feb 28, 13 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 2 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
| C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 9696308 | 2017 | Use of at least one biomarker for the in vitro prognosis or diagnosis of lymphoproliferative episodes associated with the Epstein-Barr virus (EBV) | 0 |
| 2015/0239,959 | 2015 | Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions | 0 |
| 2014/0342,349 | 2014 | USE OF AT LEAST ONE BIOMARKER FOR THE IN VITRO PROGNOSIS OR DIAGNOSIS OF LYMPHOPROLIFERATIVE EPISODES ASSOCIATED WITH THE EPSTEIN-BARR VIRUS (EBV) | 0 |
| 2013/0052,187 | 2013 | Antibodies Directed Against Hepatitis C Virus E1E2 Complex, Compositions of HCV Particles, and Pharmaceutical Compositions | 0 |
| 2011/0311,551 | 2011 | ANTIBODIES DIRECTED AGAINST HEPATITIS C VIRUS E1E2 COMPLEX, COMPOSITIONS OF HCV PARTICLES, AND PHARMACEUTICAL COMPOSITIONS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.